Marker Therapeutics Inc (MRKR)

[hanscott]

Marv I'm not sure what you mean by "no longer in complete remission (CR)"? I assume you are referring to the poster LadyLuck posted?

In the Multiple Myeloma study only one person relapsed out of the (evaluable) six that were in CR.

The results for the group that had active disease sound impressive but are hard to evaluate without a comparison with an untreated control group, or without knowing what might be the expected outcome for those patients if they did not receive multiTAA-specific T cells to treat their active disease.

I think this is covered a fair amount in Dr. Ann Lee's presentation. It looks like they have added three more individuals to the Active Disease group between Dr. Lee's presentation and the current presentation in LadyLuck's post.

Here is the link set to start where she discusses Multiple Myeloma results: